For Research Use Only. Not for human or veterinary use.
Hypothemycin
Product ID: BLK-1590
Structure
CAS
76958-67-3
Molecular Formula
C19H22O8
Molecular Weight
378.38
Price
1mg: USD 200.00 / 5mg: - / 25mg: -
Storage
-20°C
Solubility
1mg/ml ethanol, methanol, DMSO
Purity
>95%
Source Organism
Hypomyces subiculosus
Summary
Hypothemycin Resorcylic acid lactone that inhibits Ras-driven signaling and tumor cell proliferation.
Details
Hypothemycin is a resorcylic acid lactone (RAL) natural product originally isolated from Hypomyces species and later identified as a covalent inhibitor of specific serine/threonine kinases within the Ras/MAPK pathway. In Ras-transformed cells, hypothemycin suppresses Ras-responsive gene expression and inhibits anchorage-independent growth. Mechanistically, it accelerates cyclin D1 degradation via enhancement of ubiquitination and proteasome-dependent turnover, resulting in G1 phase prolongation. It also inhibits ERK1/2 phosphorylation and modulates cytokine production during T cell activation, indicating interference with MAPK-dependent signaling cascades. In vivo studies demonstrate tumor growth inhibition in Ras-driven models. As a member of the RAL family, hypothemycin functions through covalent targeting of kinase active-site residues, positioning it as a prototype scaffold for irreversible kinase inhibitors.
Mechanism
Resorcylic acid lactone kinase inhibitor that binds the ATP site of serine/threonine kinases in the Ras/MAPK pathway.